实时急性肾损伤风险分层联合生物标志物指导液体管理改善危重患儿与年轻成人结局
该研究在危重患儿与年轻成人中实施TAKING FOCUS 2(TF2)方案,结合自动肾绞痛指数(RAI)、条件性尿NGAL检测及以10%–15%体重液体蓄积为目标的CRRT启动策略。比较TF2实施前后发现,TF2期启动CRRT时间更早、CRRT前液体蓄积≥15%比例更低,CRRT存活者ICU及总ICU住院时间更短,生存率更高。
要点
- 自动化RAI联合uNGAL可支持危重患儿AKI风险分层与液体管理决策。
- TF2期CRRT启动中位时间提前2天,CRRT前液体蓄积≥15%比例降低。
- TF2期CRRT存活者ICU停留及总ICU停留分别缩短6天和11天。
核心结论
- 结合风险分层与AKI生物标志物评估的自动化临床决策支持可持久降低儿童CRRT患者疾病负担。
研究设计与样本
- 前后对照研究,比较TF2实施前(2014–2021观察期内)与TF2实施后结局。
- 共286例患者、304次ICU RAI阳性入院,观察期内178例患者接受CRRT。
- TF2措施包括入院12小时自动RAI结果、RAI≥8时条件性uNGAL医嘱、以10%–15%体重液体蓄积为CRRT启动目标。
主要发现
- ICU入院至CRRT启动中位时间缩短2天(P < 0.002)。
- TF2期CRRT前液体蓄积≥15%比例更低(P < 0.02)。
- CRRT存活者CRRT停止后ICU停留与总ICU停留分别缩短6天和11天(均P < 0.02)。
- TF2期CRRT停止后至ICU出院生存率更高(P = 0.001)。
- 上述关联在各TF2年度持续存在;估计TF2实施后每例CRRT患者保守节约12,500美元医疗费用。
关键数值与推荐
- RAI在入院12小时自动计算,RAI≥8触发条件性uNGAL医嘱。
- CRRT启动目标为体重基础液体蓄积10%–15%。
临床怎么用
- 对危重患儿可于入院早期自动计算RAI,对RAI≥8者加做uNGAL以辅助AKI风险分层。
- 以体重基础液体蓄积10%–15%作为CRRT启动参考目标,避免过度液体蓄积后再启动。
- 将风险分层与生物标志物整合入临床决策支持,可能缩短CRRT患者ICU停留并提高生存率。
局限性
- 为TF2实施前后比较,非随机对照设计,原文未报告混杂因素调整细节。
- 单中心观察性数据,样本为286例患者、304次ICU RAI阳性入院,外推需谨慎。
- 成本节约为估算值,原文未报告详细成本测算方法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Critically ill admitted patients are at high risk of acute kidney injury (AKI). The renal angina index (RAI) and urinary biomarker neutrophil gelatinase-associated lipocalin (uNGAL) can aid in AKI risk assessment. We implemented the Trial in AKI using NGAL and Fluid Overload to optimize CRRT Use (TAKING FOCUS 2; TF2) to personalize fluid management and continuous renal replacement therapy (CRRT) initiation based on AKI risk and patient fluid accumulation. We compared outcomes pre-TF2 and post-TF2 initiation. METHODS: Patients admitted from July 2017 were followed-up prospectively with the following: (i) an automated RAI result at 12 hours of admission, (ii) a conditional uNGAL order for RAI ≥8, and (iii) a CRRT initiation goal at 10% to 15% weight-based fluid accumulation. RESULTS: A total of 286 patients comprised 304 intensive care unit (ICU) RAI+ admissions; 178 patients received CRRT over the observation period (2014-2021). Median time from ICU admission to CRRT initiation was 2 days shorter (P < 0.002), and ≥15% pre-CRRT fluid accumulation rate was lower in the TF2 era (P < 0.02). TF2 ICU length of stay (LOS) after CRRT discontinuation and total ICU LOS were 6 and 11 days shorter for CRRT survivors (both P < 0.02). Survival rates to ICU discharge after CRRT discontinuation were higher in the TF2 era (P = 0.001). These associations persisted in each TF2 year; we estimate a conservative $12,500 health care cost savings per CRRT patient treated after TF2 implementation. CONCLUSION: We suggest that automated clinical decision support (CDS) combining risk stratification and AKI biomarker assessment can produce durable reductions in pediatric CRRT patient morbidity.
引用
- Goldstein SL, Krallman KA, Roy JP, et al. Real-Time Acute Kidney Injury Risk Stratification-Biomarker Directed Fluid Management Improves Outcomes in Critically Ill Children and Young Adults. Kidney Int Rep. 2023. PMID: 38106571. doi:10.1016/j.ekir.2023.09.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。